MarketResearchReports.Biz

Global Anatomic Pathology Testing Market Become Dominant at CAGR of 8.26% by 2021

Latest industry research report on: Global Anatomic Pathology Testing Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts

 

Albany, NY -- (SBWIRE) -- 03/20/2017 -- The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.

Technavios analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Diagnostics
Agilent Technologies
Danaher
Roche Diagnostics
Thermo Fisher Scientific

Request Sample Copy of Report at: http://www.marketresearchreports.biz/sample/sample/1027806

Other prominent vendors
20/20 GeneSystems
Abcam
AdnaGen
Advanced Cell Diagnostics
Agendia
Angsana Molecular & Diagnostics Laboratory
AutoGenomics
Biocare Medical
Biocartis
CellMax Life
Cancer Genetics
Digipath
Enzo Biochem
Epic Sciences
Janssen Diagnostic
Monogram Biosciences
Nucleix
Omnyx
Oxford Cancer Biomarkers
RareCyte
SAKURA FINETEK USA
Tecan
VolitionRx

Market driver
Growing prevalence of cancer in demographics
For a full, detailed list, view our report

Market challenge
High initial investment and maintenance costs
For a full, detailed list, view our report

Market trend
Presence of venture capitalists in market
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?